Goldman Sachs’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.88M | Buy |
1,478,044
+453,421
| +44% | +$884K | ﹤0.01% | 3184 |
|
|
2025
Q1 | $1.8M | Sell |
1,024,623
-1,005,151
| -50% | -$1.77M | ﹤0.01% | 3428 |
|
|
2024
Q4 | $5.4M | Buy |
2,029,774
+705,604
| +53% | +$1.88M | ﹤0.01% | 2800 |
|
|
2024
Q3 | $3.03M | Buy |
1,324,170
+184,664
| +16% | +$423K | ﹤0.01% | 3079 |
|
|
2024
Q2 | $3.33M | Sell |
1,139,506
-320
| -0% | -$934 | ﹤0.01% | 2897 |
|
|
2024
Q1 | $4.15M | Buy |
1,139,826
+345,718
| +44% | +$1.26M | ﹤0.01% | 2728 |
|
|
2023
Q4 | $1.2M | Buy |
794,108
+381,555
| +92% | +$576K | ﹤0.01% | 3518 |
|
|
2023
Q3 | $553K | Sell |
412,553
-88,944
| -18% | -$119K | ﹤0.01% | 3852 |
|
|
2023
Q2 | $903K | Buy |
501,497
+103,356
| +26% | +$186K | ﹤0.01% | 3673 |
|
|
2023
Q1 | $661K | Buy |
398,141
+156,991
| +65% | +$261K | ﹤0.01% | 3925 |
|
|
2022
Q4 | $463K | Sell |
241,150
-303,197
| -56% | -$582K | ﹤0.01% | 4129 |
|
|
2022
Q3 | $1.22M | Buy |
544,347
+399,301
| +275% | +$895K | ﹤0.01% | 3707 |
|
|
2022
Q2 | $470K | Sell |
145,046
-571,399
| -80% | -$1.85M | ﹤0.01% | 4417 |
|
|
2022
Q1 | $3.77M | Buy |
716,445
+569,597
| +388% | +$3M | ﹤0.01% | 3028 |
|
|
2021
Q4 | $1.25M | Buy |
146,848
+92,075
| +168% | +$783K | ﹤0.01% | 3851 |
|
|
2021
Q3 | $545K | Sell |
54,773
-106,556
| -66% | -$1.06M | ﹤0.01% | 4337 |
|
|
2021
Q2 | $1.5M | Sell |
161,329
-58,964
| -27% | -$549K | ﹤0.01% | 3729 |
|
|
2021
Q1 | $2.3M | Buy |
220,293
+210,293
| +2,103% | +$2.2M | ﹤0.01% | 3262 |
|
|
2020
Q4 | $117K | Buy |
+10,000
| New | +$117K | ﹤0.01% | 4445 |
|